Latest News and Press Releases
Want to stay updated on the latest news?
-
REDWOOD CITY, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Gynesonics Inc., a medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is...
-
REDWOOD CITY, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Gynesonics Inc., a medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids,...
-
REDWOOD CITY, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for...
-
Gynesonics announces key executive appointments to further accelerate and expand adoption of the Sonata Treatment.
-
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
-
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
-
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
-
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
-
Gynesonics is pleased to announce that its Sonata Procedure has been used to treat over 1,000 women in the United States in 2023
-
Gynesonics' Sonata® Procedure has been used to treat over 1,000 women in the United States and approximately 6,500 women globally.